تأثیر پیش درمانی با تروگزروتین بر فیبروز میوکارد در رتهای مبتلا به سمیت قلبی ناشی از دوکسوروبیسین.
Background. Doxorubicin (DOX) is a highly effective anthracycline drug widely used in cancer treatment. Myocardial fibrosis, a key pathological consequence of DOX-induced cardiotoxicity, impairs cardiac function and increases the risk of heart failure. Troxerutin (TXR), a natural bioflavonoid, has s...
| Publicado en: | Medical Journal of Tabriz University of Medical Sciences Vol. 47; no. 3; pp. 287 - 298 |
|---|---|
| Autores principales: | , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Tabriz University of Medical Sciences
Aug2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |